Neurology
BCKDK: Unlocking a New Hypoxia-Sensitive Target to Mitigate Cerebral Ischemic Injury
This article details how BCKDK, a hypoxia-induced kinase, disrupts branched-chain amino acid metabolism to worsen neuronal injury in cerebral ischemia, highlighting its potential as a novel therapeutic target.
